Outcomes for childhood lymphoblastic leukemia (LBL) have greatly improved in recent years. However, outcomes for T-lymphoblastic leukemia (T-LBL) continue to lag behind those of B-lymphoblastic leukemia (B-LBL), due to several factors including older age at diagnosis, higher presenting leukocyte counts,...
The 3rd edition WHO Classification of hematopoietic neoplasms (WHO-HAEM3) published in 2001 was the first comprehensive classification system of myeloid neoplasms and acute leukemias. The WHO-HAEM3 included aspects of the French-American-British classification of MDS and AML [1], but also applied principles...
Our study is the most comprehensive dataset describing AML treatment landscape in Finland, including treatment outcomes and HCRU in both fit and unfit AML patient populations. What is the central finding of your work?...
Chronic lymphocytic leukemia (CLL) is a common and incurable hematological malignancy characterized by the clonal growth of malignant CD5 B-lymphocytes with delayed apoptosis that accumulate in peripheral blood, bone marrow and lymph node [1, 2]. In severe inflammation process higher vascular permeability...
AML Classifications: WHO vs ICC 2022 Update The following is a summary of the article “Definitions of Acute Myeloid Leukaemia and their clinical significance according to the WHO 2022 and ICC classification” by Donata Backhaus et al (University of Leipzig Medical Center, Germany), which...